Fucoidan activated the ERK1/2-SGK1-NHERF-1-NaPi-2a pathway, thereby ameliorating kidney injury-associated calcium and phosphorus metabolism disorders and skeletal abnormalities in CKD-MBD model rats. This evidence concerns the gene SGK1 and metabolic disease.